Pharmaceutical Folding Carton with Tamper-Evident Seal Braille Embossing

Product Overview

The Bincai Pharmaceutical Folding Carton is engineered for compliance with global pharmaceutical packaging regulations including FDA 21 CFR Part 211, EU Falsified Medicines Directive (2011/62/EU), and ISO 15378. Each carton integrates tamper-evident tear strips, Braille text embossing for accessibility compliance, child-resistant locking mechanisms, and serialization-compatible surfaces for track-and-trace systems. Manufactured by Guangdong Bincai Color Printing Co., Ltd. in a dedicated GMP-compliant production zone within our ISO 9001:2015 and FSC-certified facility, these cartons undergo pharmaceutical-grade QA including extractables testing, microbial limits verification, and batch-level traceability. Our 18,000 sqm Foshan factory produces 1.7 million folding cartons daily on KBA 1050 and Heidelberg 7+1 UV press lines.

Applications

Customization Options

Production Specifications

Quality Assurance

Manufacturing Capabilities & Equipment

Our pharmaceutical folding carton production leverages world-class press technology and precision finishing equipment across our 18,000 sqm dual-factory campus (10,000 sqm established facility + 8,000 sqm smart factory commissioned 2025) in Foshan, Guangdong:

Production capacity: 1.7 million color boxes + 220,000 rigid boxes daily across all lines. Pharmaceutical-dedicated line: 200,000 cartons/day with full serialization capability. MOQ 500 units for clinical trial and small-volume needs. Free pre-production samples with Certificate of Analysis delivered in 5-7 days.

Why Choose Bincai for Pharmaceutical Packaging

• GMP-compliant production zone — dedicated 500 sqm clean production area with HEPA filtration, controlled humidity (45–55% RH), positive air pressure, and restricted access
• 23 years of regulated packaging expertise — serving pharmaceutical, medical device, and clinical trial packaging clients worldwide since 2003
• Regulatory mastery — packaging compliant with FDA 21 CFR Part 211, EU Falsified Medicines Directive (2011/62/EU), ISO 15378, and ICH Q7 GMP guidelines
• Low-migration printing — Heidelberg 7+1 UV press with low-migration UV inks and photoinitiators, tested per EuPIA Suitability List and Swiss Ordinance Annex 6/10
• Full traceability architecture — batch-level documentation from incoming raw materials through finished cartons with camera-verified serialization at 100 units/minute
• Stability-tested materials — accelerated aging per ASTM F1980 and ICH Q1A, real-time stability programs available for long-term product compatibility
• Regulatory submission support — Type III DMF (Drug Master File) preparation assistance; change control documentation; annual product quality reviews
• Competitive MOQ — 1,000–3,000 units standard; 500-unit trial runs for clinical batch and small-volume needs
• Free pre-production samples with Certificate of Analysis in 5-7 days; full validation batch available

Sustainability & Regulatory Stewardship

• FSC Chain-of-Custody certified — all SBS and FBB board sourced from responsibly managed forests with full traceability
• Low-migration inks — EuPIA-compliant, Swiss Ordinance Annex 6/10 tested, with migration limits < 10 ppb for non-detectable substances
• Solvent-free production — water-based aqueous coatings and hot-melt adhesives with zero VOC contribution to packaged pharmaceuticals
• Recyclable design — SBS cartons accepted in standard paper recycling streams; PET tear strips easily separable for mono-material recovery
• Energy efficiency — GMP zone LED lighting reduces energy use by 60%; heat recovery from press dryers preheats incoming air
• Responsible disposal — pharmaceutical waste segregated per WHO guidelines; solvent-free process means zero hazardous air pollutant (HAP) emissions

Carton Format Comparison: Folding vs. Blister vs. Clamshell for Pharma

Folding cartons lead on cost efficiency, sustainability, serialization surface area, and regulatory compliance (Braille, tamper-evident seals). Blister packs excel at individual dose protection but lack printable surface and recyclability. Clamshells suit medical devices but offer limited tamper evidence and higher tooling costs. For pharmaceutical brands requiring EU FMD serialization, Braille embossing, and tamper-evident seals on a single SKU — folding cartons deliver the most complete compliance solution at the lowest per-unit cost.

FAQ

Are your cartons FDA compliant? Yes. Our pharmaceutical cartons comply with FDA 21 CFR Part 211 (CGMP for Finished Pharmaceuticals). We maintain full batch records, perform extractables testing per USP <1663>/<1664>, and can support Type III DMF submissions.

Can you print variable data including serial numbers and expiry dates? Yes. Our Heidelberg inkjet module prints DataMatrix codes (GS1), QR codes, human-readable lot numbers, and expiration dates inline at 100 cartons/minute with camera verification achieving >99.9% read rate.

What Braille languages do you support? We emboss pharmaceutical Braille in all EU languages per Directive 2001/83/EC Article 54a, with standard dot height of 1.6mm ±0.1mm. Non-EU Braille standards (Marrakesh Treaty signatories) also available.

Do you offer child-resistant packaging? Yes. We manufacture cartons with push-and-turn, squeeze-and-lift, and dual-button release mechanisms certified to ISO 8317 and 16 CFR § 1700.20. Senior-friendly effectiveness testing included in certification package.

What is the minimum order quantity? Standard MOQ is 1,000–3,000 units. Clinical trial and small-volume runs of 500 units are available with a modest surcharge.

How do you ensure GMP compliance? Our dedicated 500 sqm clean production zone operates under HEPA filtration with restricted access, real-time environmental monitoring, and full batch record documentation per ICH Q7. Annual third-party GMP audits conducted.

Can you support serialization for EU FMD compliance? Yes. We support EU Falsified Medicines Directive serialization with GS1 DataMatrix codes containing GTIN, serial number, batch, and expiry date. Our systems integrate with national medicines verification systems (NMVS).